Filing Details
- Accession Number:
- 0001209191-21-062670
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-03 16:05:54
- Reporting Period:
- 2021-11-01
- Accepted Time:
- 2021-11-03 16:05:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1438533 | Travere Therapeutics Inc. | TVTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221599 | Steve Aselage | C/O Travere Therapeutics, Inc. 3611 Valley Centre Dr., Suite 300 San Diego CA 92130 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-02-04 | 25,000 | $0.00 | 164,794 | No | 5 | G | Direct | |
| Common Stock | Acquisiton | 2021-02-04 | 25,000 | $0.00 | 25,000 | No | 5 | G | Indirect | See footnote |
| Common Stock | Disposition | 2021-07-16 | 3,000 | $0.00 | 161,794 | No | 5 | G | Direct | |
| Common Stock | Acquisiton | 2021-07-16 | 3,000 | $0.00 | 28,000 | No | 5 | G | Indirect | See footnote |
| Common Stock | Disposition | 2021-11-01 | 5,000 | $29.48 | 23,000 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2021-11-02 | 3,500 | $30.00 | 19,500 | No | 4 | S | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 5 | G | Indirect | See footnote |
| No | 5 | G | Direct | |
| No | 5 | G | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
Footnotes
- The shares are held in the name of the Aselage Family Trust.
- The sales reported in this Form 4 were effected pursuant to an automatic trading plan adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.065 to $29.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Billionaire Hedge Funds
